Literature DB >> 19958859

Long-term morbidity and mortality among medically managed patients with angina and multivessel coronary artery disease.

Matthew A Cavender1, Karen P Alexander, Samuel Broderick, Linda K Shaw, Charles B McCants, Judith Kempf, E Magnus Ohman.   

Abstract

BACKGROUND: There are little data regarding outcomes in patients with angina and severe coronary artery disease (CAD) treated with medical management. Using the Duke Databank of Cardiovascular Disease, we describe the prevalence and long-term outcomes of patients with angina and multivessel CAD treated medically after catheterization.
METHODS: Patients undergoing catheterization for angina (chest pain without recent revascularization or myocardial infarction) with severe CAD (>or=75% stenosis in >or=2 epicardial vessels) were identified (n = 8,555). One and five year outcomes in the 32% (n = 2,776) of patients who did not receive revascularization in the 30 days after catheterization were described. Predictors of 1-year death, cardiac rehospitalization, and late revascularization in this population were identified.
RESULTS: The population had a median age of 66, were mostly male, had significant comorbidities, and most had prior revascularization. Outcomes were poor at 1 and 5 years: death (11% and 37%), cardiac rehospitalization (29% and 61%), and late revascularization (10% and 27%). The cumulative rate of death, myocardial infarction, late revascularization, or cardiac rehospitalization occurred in 38% at 1 year and 76% at 5 years. Prior coronary artery bypass grafting was the only variable independently associated with protection from death, cardiac rehospitalization, and late revascularization.
CONCLUSIONS: Medical management after catheterization is a common in patients with severe CAD and angina. Of patients treated with medical management, one third will have a recurrent cardiac event within the first year highlighting the poor outcomes and high utilization of resources by this patient population.

Entities:  

Mesh:

Year:  2009        PMID: 19958859     DOI: 10.1016/j.ahj.2009.10.013

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  7 in total

1.  Association between having a caregiver and clinical outcomes 1 year after hospitalization for cardiovascular disease.

Authors:  Lori Mosca; Brooke Aggarwal; Heidi Mochari-Greenberger; Ming Liao; Judith Blair; Bin Cheng; Mariceli Comellas; Lisa Rehm; Niurka Suero-Tejeda; Tianna Umann
Journal:  Am J Cardiol       Date:  2011-09-29       Impact factor: 2.778

Review 2.  Contemporary Management of Refractory Angina.

Authors:  Rebekah Lantz; Odayme Quesada; Georgia Mattingly; Timothy D Henry
Journal:  Interv Cardiol Clin       Date:  2022-07

Review 3.  Recent advances in the management of chronic stable angina II. Anti-ischemic therapy, options for refractory angina, risk factor reduction, and revascularization.

Authors:  Richard Kones
Journal:  Vasc Health Risk Manag       Date:  2010-09-07

4.  Predictors of long-term clinical endpoints in patients with refractory angina.

Authors:  Thomas J Povsic; Samuel Broderick; Kevin J Anstrom; Linda K Shaw; E Magnus Ohman; Eric L Eisenstein; Peter K Smith; John H Alexander
Journal:  J Am Heart Assoc       Date:  2015-01-30       Impact factor: 5.501

5.  Association of helicobacter pylori infection with severity of coronary heart disease.

Authors:  Mehran Rogha; Davood Dadkhah; Zahra Pourmoghaddas; Keivan Shirneshan; Marjan Nikvarz; Masoud Pourmoghaddas
Journal:  ARYA Atheroscler       Date:  2012

6.  The chromosome 9p21 variant not predicting long-term cardiovascular mortality in Chinese with established coronary artery disease: an eleven-year follow-up study.

Authors:  I-Te Lee; Mark O Goodarzi; Wen-Jane Lee; Jerome I Rotter; Yii-der Ida Chen; Kae-Woei Liang; Wen-Lieng Lee; Wayne H-H Sheu
Journal:  Biomed Res Int       Date:  2014-04-02       Impact factor: 3.411

7.  Value of Chromosome 9p21 Polymorphism for Prediction of Cardiovascular Mortality in Han Chinese Without Coronary Lesions: An Observational Study.

Authors:  I-Te Lee; Kae-Woei Liang; Jun-Sing Wang; Wen-Jane Lee; Yii-der Ida Chen; Shih-Yi Lin; Wen-Lieng Lee; Wayne H-H Sheu
Journal:  Medicine (Baltimore)       Date:  2015-09       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.